Navigation Links
$7.5 million to JAX from South Korean government for cancer genomics project
Date:1/22/2014

The Jackson Laboratory, in collaboration with Seoul National University, will receive a five-year, $7.5 million grant from the South Korean government for a large-scale cancer genomics project employing the latest sequencing technology and special JAX mouse models that can host human tumors.

"This is a wonderful example of the international collaborations that JAX is building to rapidly advance its research mission, in this case: individualized cancer diagnosis and treatment," said Charles Lee, Ph.D., director of The Jackson Laboratory for Genomic Medicine and leader of the JAX component of the project,

Lee, who is also a distinguished visiting professor at Seoul National University, will work with principal investigator Jong-Il Kim, M.D., Ph.D., of the Seoul National University College of Medicine and other academic collaborators in Seoul.

During the first phase of the grant (2013-15), Kim and colleagues will collect and store tumors from patients with gastric, breast, colon, lung and rare cancers, and sequence and determine the genomic signatures of those cancers.

Lee will lead the development of hundreds of new mouse model systems for gastric, breast and other cancers that will be made available to the worldwide scientific community. The so-called PDX models (for patient-derived xenograft) represent mice that carry human tumors, enabling detailed functional study of the cellular and genomic characteristics of specific cancers.

The research team will also build a publicly accessible library of anticancer drugs and establish a drug efficacy screening system using patient-derived primary cell lines and PDX mouse models.

Lee explains that the researchers expect to find genetic similarities among certain cancers. "If we look at 1,000 gastric cancers, their genetic signatures may group into, say, 20 clusters. We can then do preclinical testing on just a few tumors from each of those groups, testing different drugs or combinations of drugs to determine which therapies are most effective for treating those tumors with a given genetic signature."

During the grant's second phase (2016-17), the researchers will take the project to the clinic, developing a personalized anticancer drug screening system and establishing a clinical trial network for individualized medicinal screening.

"This grant from the South Korean government shows there's international interest in The Jackson Laboratory's approach to cancer research using PDX models," Lee says.


'/>"/>

Contact: Joyce Peterson
joyce.peterson@jax.org
207-288-6058
Jackson Laboratory
Source:Eurekalert

Related biology news :

1. Dartmouth-led team gets $8 million grant to research arsenic in children
2. With $1.6 million award, biochemist tackles diabetes
3. Autism Speaks awards nearly $2.7 million for new research projects
4. After a 49-million-year hiatus, a cockroach reappears in North America
5. Physicians awarded $4 million to study effects of fertility treatments and obstetric care
6. Algae to crude oil: Million-year natural process takes minutes in the lab
7. UT Dallas awarded $1 million to improve prosthetics for soldiers
8. Pitt-led network gets $70 million over 7 years to develop, test HIV prevention products
9. A new species of horse, 4.4 million years old
10. EPA awards $1 million grant to NJITs Brownfield program
11. Army renews bio-inspired engineering and science research center at UC Santa Barbara with $48 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
Breaking Biology Technology: